Cardiomyopathy Gene Panel in UAE | 4800 AED | DHA Licensed

Executive Summary & Core Metrics

Executive Summary

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited Next‑Generation Sequencing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection for blood samples (Available daily from 8 AM to 11 PM). For prenatal specimens (amniotic fluid, chorionic villi), collection is performed strictly at an accredited hospital facility.
Clinical Guidance: Post‑Test Genetic Counseling by a DHA‑licensed Consultant Medical Geneticist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Cardiomyopathy Gene Panel is a comprehensive Next‑Generation Sequencing (NGS) assay that simultaneously analyzes more than 70 genes linked to inherited cardiomyopathies, delivering definitive molecular insights for tailored cardiac care.

Feature	Our Test	Closest Alternative
Precision	99.9% Analytical Sensitivity (NGS)	~95% (Sanger‑based limited panels)
Method	NGS with full exon coverage & copy number variant detection	Single‑gene or small multi‑gene Sanger sequencing
Turnaround	4–6 Weeks	8–12 Weeks

Physician Insight & Safety Protocols

“A cardiomyopathy gene panel provides critical information for patients with suspected hereditary cardiac conditions. However, results must be interpreted in the context of clinical findings and family history. Genetic counseling is recommended for all patients undergoing testing.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403

Medication Advisory

⚠️ Medication Advisory: Do not discontinue prescribed medication without consulting your doctor. Genetic test results should be reviewed by a cardiologist or clinical geneticist before any change in management.

Exclusion Criteria & Emergency Red Flags

Exclusion: Active febrile illness or acute decompensated heart failure – resample after stabilization.
Exclusion: Inability to provide at least 2 mL of peripheral blood, or inability to undergo amniocentesis/CVS as indicated.
ER Red Flags: Sudden chest pain, syncope, or sustained ventricular tachycardia while awaiting results – seek immediate emergency care.
Minor Consent: For patients under 18, parental/legal guardian consent and a paediatric cardiologist referral are mandatory per Federal Decree-Law No. 4 of 2016 on Medical Liability.

Patient FAQ & Clinical Guidance

1. What is the cardiomyopathy gene panel and who should consider it?

A cardiomyopathy gene panel is a comprehensive genetic test that analyses more than 70 genes linked to inherited heart muscle diseases. It is recommended for individuals with a family history of cardiomyopathy, unexplained heart failure, or sudden cardiac death at a young age.

2. How is the sample collected and what is the turnaround time?

A sample of peripheral blood, amniotic fluid, or chorionic villi is collected by a certified phlebotomist or specialist in a clinic/hospital. Results are typically ready in 4 to 6 weeks after the laboratory receives the sample.

3. What happens if a variant of uncertain significance (VUS) is found?

A variant of uncertain significance means the genetic change’s effect on heart muscle function is not yet clearly understood. Your cardiologist may recommend periodic re‑evaluation of the result as scientific knowledge advances, and clinical decisions should be based on the overall picture.

UAE Regulatory & Data Privacy Adherence

This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and medical liability are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. A valid doctor’s prescription is required; may be waived for surgical clearance, pregnancy, or pre‑travel screening.

Clinical & Logistical Metadata

Test Name	Cardiomyopathy Gene Panel (NGS, 70+ genes)
Price (AED)	4,800 AED
Turnaround Time	4–6 Weeks
Sample Type / Matrix	Peripheral blood, amniotic fluid, chorionic villi
Methodology Used	Next‑Generation Sequencing (NGS) with full exon coverage & CNV detection
ICD-10-CM Code	I42.9, I42.0, I42.1, I42.2
LOINC Code	95007-1
DHA Facility License & Laboratory Address	DHA License: 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE